Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TCEHY | ABBV |
|---|---|---|
| Price | $54.84 | $265.76 |
| Change today | ▲ 3.26% | ▲ 1.12% |
| Market cap | $478.35B | $469.63B |
| Return, 3 months | -6.9% | +5.1% |
| Return, year to date | -27.5% | +19.1% |
| Return, 1 year | -36.5% | +19.0% |
| P/E (TTM) | 15.1 | 75.1 |
| P/B | 2.9 | -79.1 |
| P/E percentile vs own 5y | – | 70th |
| Dividend yield | 1.27% | 2.54% |
| Revenue growth (YoY, latest qtr) | – | +10.2% |
| Net profit growth (YoY) | – | +284.3% |
| Gross margin | – | 71.5% |
| Operating margin | – | 33.9% |
| Net margin | – | 9.7% |
| Return on equity | – | – |
| Analyst target vs. price | – | +7.9% |
| Analyst buy share | – | 90% |
| RSI (14) | 42 | 58 |
| 30-day volatility | 27.6% | 17.0% |
| Max drawdown, 1 year | -38.5% | -17.3% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
